Delivery Order SPE2DB22D6029-SPE2DB24FU1CB

Award Date 5/29/24
Potential Completion Date 5/30/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at up to $16,585.84, is for the delivery of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" and has a completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $6,322.56 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" with a completion date of May 21, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a $1,053.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This delivery order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,241.34 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which runs through June 2024, is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML." Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the federal government, is providing these products to support DLA Troop Support Medical's mission to procure...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,260.46 firm fixed-price delivery order is for the supply of the pharmaceutical product "ZEPBOUND 10 MG/0.5 ML PEN 0.5ML" with a completion date of July 3, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the supply of 4564654078 ! ZEPBOUND 10 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $3,261.31 delivery order contract has a completion date of May 21, 2024 and is a firm fixed price instrument. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,069.45 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA), a defense agency. The award is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,318.33, is a Firm Fixed Price Delivery Order with an ultimate completion date of January 7, 2025. The contract covers the supply of pharmaceutical products, including the ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medication. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $4,559.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of May 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,380.66 firm fixed price delivery order is for the supply of 4564167004 - ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB24FU1CB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" to the Defense Logistics Agency (DLA). The contract, valued at $2,634.40, is a Firm Fixed Price Delivery Order with a completion date of May 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/28/24, 11:09 AM